Promacta 50 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT7Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,496
Award facts
- Contract value 100% obligated
- $18,496.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,496.44 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle that extends through December 2026 and serves as the primary mechanism for delivering comprehensive pharmaceutical and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and established federal contractor with an extensive portfolio of medical product deliveries to the Defense Logistics Agency and other federal healthcare systems. The company's competitively awarded contracts demonstrate its capability to fulfill federal procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. Promacta (eltrombopag) is an immune thrombocytopenia treatment, reflective of the specialized pharmaceutical commodities that AmerisourceBergen regularly supplies to support military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FQT7Q?
SPE2DR26FQT7Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FQT7Q worth?
The government has obligated $18,496 on SPE2DR26FQT7Q.
Is contract SPE2DR26FQT7Q an order under another contract?
Yes. SPE2DR26FQT7Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT7Q competed?
The extent of competition for SPE2DR26FQT7Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award